Menu
1-702-720-6310 info@microcapspecualtors.com

Cara Therapeutics Reports Second Quarter 2016 Financial Results

[at noodls] – – Resumed patient enrollment in adaptive pivotal trial of I.V. CR845 in post-operative pain – – Initiated adaptive Phase 2/3 trial for I.V. CR845 in dialysis patients with uremic pruritus – – Initiation …
Source: New feed

Search